MediciNova Inc (NASDAQ:MNOV)

8.61
Delayed Data
As of Jun 22
 +0.05 / +0.58%
Today’s Change
4.40
Today|||52-Week Range
14.50
+33.08%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$424.5M

Company Description

MediciNova, Inc. is a biopharmaceutical company, which engages in acquiring and developing novel, small molecule therapeutics for the treatment of serious diseases for the treatment of diseases with unmet medical need. The firm's development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.

Contact Information

MediciNova, Inc.
4275 Executive Square
La Jolla California 92037
P:(858) 373-1500
Investor Relations:

Employees

Shareholders

Individual stakeholders9.74%
Other institutional8.81%
Mutual fund holders11.19%

Top Executives

Yuichi IwakiPresident, Chief Executive Officer & Director
Carla ReyesChief Financial Officer
Kazuko MatsudaChief Medical Officer
Masatsune OkajimaVice President & Head-Japanese Office
Geoffrey G. O'BrienVice President